IP Library Assignment 050798/0522
Patent Assignment
Reel/Frame 050798/0522

Confirmatory Intellectual Property Assignment

Recorded: 2019-10-23 Pages: 9
Assignor
THERAPURE BIOPHARMA, INC.
Executed: 2019-10-22
Assignee
EVOLVE BIOLOGICS INC.
420 AMBASSADOR DRIVE, MISSISSAUGA, L5T 2J3, CANADA
Covered Properties (4)
Process For Isolation Of Plasma Or Serum Proteins
Patent: 9,624,260 →
Application: 11/570,154 →
Publication: US 2007/0299251
Process for Isolation of Plasma or Serum Proteins
Patent: 9,428,545 →
Application: 14/688,906 →
Publication: US 2016/0009757
Process For Isolation of Plasma or Serum Proteins
Application: 15/451,743 →
Publication: US 2017/0282095
Method for Purification of Albumin
Application: 16/492,766 →
Publication: US 2021/0139534
Related Assignments (10)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 13, 2007
From: LIHME, ALLAN OTTO FOG
To: UPFRONT CHROMATOGRAPHY A/S
Reel/Frame 019598/0284 →
Assignment of Assignor's Interest Jul 8, 2013
From: UPFRONT CHROMATOGRAPHY A/S
To: THERAPURE BIOPHARMA INC.
Reel/Frame 030752/0746 →
Security Interest Nov 23, 2015
From: THERAPURE BIOPHARMA INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 037116/0471 →
Assignment of Assignor's Interest Jun 7, 2017
From: LIHME, ALLAN OTTO FOG
To: UPFRONT CHROMATOGRAPHY A/S
Reel/Frame 042626/0258 →
Assignment of Assignor's Interest Jun 7, 2017
From: UPFRONT CHROMATOGRAPHY A/S
To: THERAPURE BIOPHARMA INC.
Reel/Frame 042626/0343 →
Assignment of Assignor's Interest Sep 10, 2019
From: SEO, JIN SEOG; MILLER, DAVID
To: THERAPURE BIOPHARMA INC.
Reel/Frame 050327/0328 →
Intellectual Property Security Agreement Oct 22, 2019
From: THERAPURE BIOPHARMA INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 050797/0377 →
Release of Security Interest Oct 21, 2020
From: MIDCAP FINANCIAL TRUST
To: THERAPURE BIOPHARMA INC.
Reel/Frame 054123/0837 →
Release of Security Interest Oct 21, 2020
From: MIDCAP FINANCIAL TRUST
To: EVOLVE BIOLOGICS INC.
Reel/Frame 054123/0957 →
Security Interest May 31, 2023
From: EVOLVE BIOLOGICS INC.; TBI PHARMA HOLDINGS LTD.
To: MONROE CAPITAL MANAGEMENT ADVISORS, LLC
Reel/Frame 063817/0151 →